- Home
- Articles
- canada quebec
- clinical outcome
Refine by
Clinical Outcome Articles & Analysis
53 articles found
You’ve built an aesthetic practice with trained staff and a loyal patient base. As demand grows and competition increases, selecting the right laser platform becomes a strategic decision with implications for service mix, operational efficiency, patient satisfaction, and ROI over the long term.This article outlines how to differentiate scalable, modular platforms from single device systems, why ...
Launching a medspa is capital-intensive. Equipment decisions shape your treatment menu, clinical outcomes, patient experience, workflow efficiency, and long-term profitability. The goal is alignment: your devices should support your clinical philosophy, staffing model, and revenue strategy, not drive them. This guide outlines the essential equipment categories to evaluate before launching a ...
Why Routine Inspection, Cleaning/Disinfection, Manufacturer Checkups, and Backup Systems Matter Summary Dental and surgical loupes are not just magnification devices; they are clinical tools that impact infection control, visual performance, precision, and clinician posture. As a wearable device used in patient care environments, dental and surgical loupes are exposed to aerosols, spatters, ...
As the end of the year approaches, many clinicians look for smart ways to invest in their practice while reducing taxable income. One powerful opportunity often overlooked is the Section 179 tax deduction — a U.S. tax incentive that allows businesses, including dental and medical practices, to deduct the full purchase price of qualifying equipment in the year it is placed in service. If ...
At first glance, a cheaper drainage bag may seem like a smart move for a tight budget. But procurement teams know the real cost of a product goes far beyond the price on the invoice. When medical drainage bags fail to perform, the ripple effects show up in the form of surgical delays, patient dissatisfaction, and even infection risk. Discover the hidden costs of low-quality drainage ...
Ischaemic heart diseases continue to be a major global health concern and a leading cause of death. To develop more effective treatments, it is essential for researchers to work with animal models that closely replicate human cardiac physiology. In a notable step forward, Pius et al. present a refined, minimally invasive ovine model of ischaemia–reperfusion–infarction which ...
For decades, the medical field has seen incredible advances in technology – from new diagnostic capabilities to improved treatments that have saved countless lives. One of these impressive solutions is radiopaque markers – small devices used to diagnose and treat a variety of conditions, ranging from cardiovascular problems to cancer. Not only do they help doctors better understand ...
On Wednesday, 27th November, the National Institute for Health and Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN) updated and published a joint guideline on asthma diagnosis, monitoring, and chronic asthma management. Streamlining asthma management BTS/SIGN and NICE published guidelines independent of each other. To align ...
Clinical trials are the backbone of modern medicine, responsible for bringing innovative, safe, and efficient treatments to market after rigorous testing and evaluation. However, the conventional process of conducting these trials has often been long, expensive, and fraught with inefficiencies¹. The advent of predictive analytics is reshaping the landscape of clinical trials, ushering in a ...
Host cell proteins (HCPs) are process-related impurities produced by host cells and are typically present at low levels in recombinant biopharmaceutical products. Enzyme-linked immunosorbent assay (ELISA) has traditionally been used to monitor the total content of HCP in the production of therapeutic protein drugs. Now, with the continuous improvement and upgrading of technology, liquid ...
One of the main benefits of using Nuvonis’ fully tested GMP Vero cells is the unparalleled speed towards clinical trials. A case example from one of our customers, hVIVO: First contact with Nuvonis in July 2020, due diligence, contracting, provision of GMP Vero cells and protocols, as well as full documentation Production of GMP material in November 2020 ...
ByNuvonis
REAL is a phase 2a open-label study to assess preliminary safety, tolerability, and effect on clinical outcomes as well as neurodegeneration biomarkers of BRAVYL in patients with ALS. The study will enroll approximately 20 patients, all of whom will be treated with BRAVYL for 24 weeks. ...
Summary In this Cell Patterns publication, Ozette co-founders and collaborators at the Cancer Immunotherapy Trials Network (CITN) outline a novel method of analysis of single cell data, FAUST, and validate the multiple potential applications. The paper tackles 2 important problems: 1) analysis of complex single cell datasets; 2) prediction of response to immunotherapy in cancer. Manual ...
December 2022 edition Given the regular posts of peer-reviewed scientific publications on the Medis QFR®, it is clear that this angio-based solution for coronary physiology is extensively used in clinical research and practice. We would like to share these publications with you so that you remain up to date about the research that is ongoing worldwide with this innovative solution, ...
With the emergence of COVID-19, Decentralisation of Clinical Trials became necessary to comply with social distancing requirements while carrying out clinical research. Over the past few years, the clinical trial landscape has shifted its focus to patient-centric practices to promote patient engagement. But now as the pandemic is long gone, it is time to reflect on how DCT studies are genuinely ...
ByClinion
With the rising demand for improving patient safety in clinical trials, the adoption of patient-centric solutions is considered the best route to enhance data accuracy and experience automated workflows. This is where eCOA comes into play. In this blog post, we will find out how electronic clinical outcome assessments are helping the clinical trials industry handle the ever-growing list of ...
ByClinion
Abstract Lung cancer mortality remains high even after successful resection. Adjuvant treatment benefits stage II and III patients, but not stage I patients, and most studies fail to predict recurrence in stage I patients. Our study included 211 lung adenocarcinoma patients (stages I–IIIA; 81% stage I) who received curative resections at Taipei Veterans General Hospital between January ...
Abstract Laparoscopic cholecystectomy has proven to be a safe and effective procedure, with low rates of com- plications and mortality since its introduction in the late 1980s. However, surgeons have been working to develop alternatives to this technique to improve clinical outcomes and the level of patient satisfaction. Natural orifice trans- luminal endoscopic surgery (NOTES) is one such ...
Liposomes are a novel drug delivery system (DDS). They are bimolecular vesicles that form spontaneously when phospholipids are dispersed in water. Liposomes vary in size, composition and charge and can be used as carriers for a wide range of drug molecules, such as chemotherapeutic agents, antimicrobial and antiviral drugs, antiparasitic drugs, genetic material, vaccines, therapeutic proteins, ...
Many cell and gene therapy solutions have shown considerable promise as a source of possible treatments for a wide range of chronic disorders. However, these sophisticated therapies introduce additional barriers such as the requirements for ultra-low and cryogenic storage, which affect numerous steps of the biomedical solutions’ life cycles, from their development to their administration. ...